NO322334B1 - Lyofilisert preparat av human benmorfogenetisk faktor MP52, og fremgangsmate for fremstilling av et lyofilisert preparat av human benmorfogenetisk faktor MP52 - Google Patents

Lyofilisert preparat av human benmorfogenetisk faktor MP52, og fremgangsmate for fremstilling av et lyofilisert preparat av human benmorfogenetisk faktor MP52 Download PDF

Info

Publication number
NO322334B1
NO322334B1 NO19993702A NO993702A NO322334B1 NO 322334 B1 NO322334 B1 NO 322334B1 NO 19993702 A NO19993702 A NO 19993702A NO 993702 A NO993702 A NO 993702A NO 322334 B1 NO322334 B1 NO 322334B1
Authority
NO
Norway
Prior art keywords
bone morphogenetic
human bone
morphogenetic factor
lyophilized preparation
mannitol
Prior art date
Application number
NO19993702A
Other languages
English (en)
Norwegian (no)
Other versions
NO993702D0 (no
NO993702L (no
Inventor
Hideki Ichikawa
Mitsuko Inagaki
Original Assignee
Bioph Biotech Entw Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioph Biotech Entw Pharm Gmbh filed Critical Bioph Biotech Entw Pharm Gmbh
Publication of NO993702D0 publication Critical patent/NO993702D0/no
Publication of NO993702L publication Critical patent/NO993702L/no
Publication of NO322334B1 publication Critical patent/NO322334B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19993702A 1997-01-30 1999-07-29 Lyofilisert preparat av human benmorfogenetisk faktor MP52, og fremgangsmate for fremstilling av et lyofilisert preparat av human benmorfogenetisk faktor MP52 NO322334B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1634997 1997-01-30
PCT/JP1998/000371 WO1998033514A1 (en) 1997-01-30 1998-01-29 Freeze-dried composition of bone morphogenetic protein human mp52

Publications (3)

Publication Number Publication Date
NO993702D0 NO993702D0 (no) 1999-07-29
NO993702L NO993702L (no) 1999-09-29
NO322334B1 true NO322334B1 (no) 2006-09-18

Family

ID=11913900

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993702A NO322334B1 (no) 1997-01-30 1999-07-29 Lyofilisert preparat av human benmorfogenetisk faktor MP52, og fremgangsmate for fremstilling av et lyofilisert preparat av human benmorfogenetisk faktor MP52

Country Status (22)

Country Link
EP (1) EP0972520B9 (sr)
JP (1) JP4209948B2 (sr)
KR (1) KR100548107B1 (sr)
CN (1) CN1152712C (sr)
AP (1) AP983A (sr)
AT (1) ATE302021T1 (sr)
AU (1) AU737595B2 (sr)
BR (1) BR9807537B1 (sr)
CA (1) CA2278546C (sr)
DE (1) DE69831223T9 (sr)
DK (1) DK0972520T3 (sr)
EA (1) EA001579B1 (sr)
ES (1) ES2244043T3 (sr)
HU (1) HU226554B1 (sr)
IL (2) IL130967A0 (sr)
NO (1) NO322334B1 (sr)
NZ (1) NZ336509A (sr)
PL (1) PL189381B1 (sr)
RS (1) RS49691B (sr)
SI (1) SI0972520T1 (sr)
TR (1) TR199901832T2 (sr)
WO (1) WO1998033514A1 (sr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957943B2 (en) † 1997-02-07 2008-11-26 Stryker Corporation Matrix-free osteogenic devices, implants and methods of use thereof
WO2003030873A1 (en) * 2001-10-09 2003-04-17 Cellfactors Plc Therapeutic biological product and method for formation of new vascularised bone
ATE303169T1 (de) 2001-11-19 2005-09-15 Scil Technology Gmbh Homogen beschichtete vorrichtung mit osteoinduktiven und osteokonduktiven eigenschaften
AU2003253049A1 (en) 2002-09-10 2004-04-30 Scil Technology Gmbh Metal implant coated under reduced oxygen concentration with osteoinductive protein
US20060204511A1 (en) * 2003-08-05 2006-09-14 Bouwstra Jan B Use of recombinant or synthetic gelatin as stabiliser in vaccines
CA2545458A1 (en) * 2003-11-10 2005-05-26 Arriva-Prometic Inc. Dry recombinant human alpha 1-antitrypsin formulation
US8372419B2 (en) 2004-03-10 2013-02-12 Scil Technology Gmbh Coated implants, their manufacturing and use thereof
US10360287B2 (en) 2015-05-22 2019-07-23 Microsoft Technology Licensing, Llc Unified messaging platform and interface for providing user callouts
US20160344677A1 (en) 2015-05-22 2016-11-24 Microsoft Technology Licensing, Llc Unified messaging platform for providing interactive semantic objects

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
WO1993000050A1 (en) * 1991-06-21 1993-01-07 Genetics Institute, Inc. Pharmaceutical formulations of osteogenic proteins
JP2966592B2 (ja) * 1991-07-20 1999-10-25 萩原 義秀 安定化されたヒトモノクローナル抗体製剤
DK0625989T3 (da) * 1992-02-12 2000-06-26 Bioph Biotech Entw Pharm Gmbh DNA-sekvenser kodende for hidtil ukendte vækst-/differentieringsfaktorer
CA2093836A1 (en) * 1992-04-24 1993-10-25 Wayne Gombotz Biodegradable tgf-.beta. delivery system for bone regeneration
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
WO1996029095A1 (en) * 1995-03-21 1996-09-26 Applied Research Systems Ars Holding N.V. Hcg liquid formulations
DE69636728T4 (de) * 1995-04-19 2007-06-28 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Neues protein und verfahren zu dessen herstellung

Also Published As

Publication number Publication date
TR199901832T2 (xx) 1999-12-21
JP4209948B2 (ja) 2009-01-14
HUP0002386A3 (en) 2002-09-30
NZ336509A (en) 2001-03-30
CA2278546C (en) 2008-04-01
YU34999A (sh) 2002-08-12
KR20000070586A (ko) 2000-11-25
AU5679198A (en) 1998-08-25
RS49691B (sr) 2007-12-31
SI0972520T1 (sl) 2006-02-28
NO993702D0 (no) 1999-07-29
DE69831223D1 (de) 2005-09-22
WO1998033514A1 (en) 1998-08-06
ES2244043T3 (es) 2005-12-01
EP0972520B1 (en) 2005-08-17
AU737595B2 (en) 2001-08-23
NO993702L (no) 1999-09-29
BR9807537A (pt) 2000-03-21
EA199900694A1 (ru) 2000-04-24
PL189381B1 (pl) 2005-07-29
DK0972520T3 (da) 2005-12-19
IL130967A0 (en) 2001-01-28
HUP0002386A2 (hu) 2000-11-28
ATE302021T1 (de) 2005-09-15
IL130967A (en) 2006-12-10
EP0972520A4 (en) 2002-11-05
CA2278546A1 (en) 1998-08-06
CN1152712C (zh) 2004-06-09
EP0972520A1 (en) 2000-01-19
EP0972520B9 (en) 2006-03-22
KR100548107B1 (ko) 2006-02-02
PL334852A1 (en) 2000-03-27
AP983A (en) 2001-07-16
CN1244127A (zh) 2000-02-09
AP9901602A0 (en) 1999-09-30
BR9807537B1 (pt) 2009-01-13
DE69831223T9 (de) 2006-12-07
DE69831223T2 (de) 2006-02-16
EA001579B1 (ru) 2001-06-25
HU226554B1 (en) 2009-03-30

Similar Documents

Publication Publication Date Title
KR100365171B1 (ko) 약학적으로안정한옥살리플라티늄제제
PT89835B (pt) Processo para a preparacao de uma formulacao de relaxina humana
US6150331A (en) Human growth hormone-containing aqueous pharmaceutical composition
KR20040074099A (ko) Ｅｇｆ 수용체에 대한 항체를 함유하는 동결건조된 제제
JP2002511103A (ja) アミリン作動薬ペプチド用製剤
US5028587A (en) Mixed crystals of insulin and insulin derivatives
EP0143478B1 (en) Stable, aqueous, acidic solution of cis-platinum, suitable for injection
KR100955075B1 (ko) 실크 펩타이드를 활성성분으로 함유하는 골다공증 예방 및치료용 조성물
NO322334B1 (no) Lyofilisert preparat av human benmorfogenetisk faktor MP52, og fremgangsmate for fremstilling av et lyofilisert preparat av human benmorfogenetisk faktor MP52
KR970000507B1 (ko) 안정된 안트라사이클린 제제
RU2272623C2 (ru) РАСТВОР ТЕТРАГИДРАТА МОНОНАТРИЕВОЙ СОЛИ N-[O-(п-ПИВАЛОИЛОКСИБЕНЗОЛСУЛЬФОНИЛАМИНО)БЕНЗОИЛ]ГЛИЦИНА И ГОТОВАЯ ЛЕКАРСТВЕННАЯ ФОРМА НА ЕГО ОСНОВЕ
JPH0610138B2 (ja) スーパーオキシドディスムターゼ組成物
JPWO1998033514A1 (ja) 骨誘導因子ヒトｍｐ５２凍結乾燥組成物
US20040132653A1 (en) Lyophilized composition of bone morphogenetic factor human MP52
MXPA99006784A (en) Freeze-dried composition of bone morphogenetic protein human mp52
JPH026335B2 (sr)
HU208074B (en) Process for producing stable cisplatine solutions and lyophilized preparation
RU1836080C (ru) Способ получени лиофилизата
US20030139468A1 (en) Amiodarone solutions suitable for intravenous administration
WO2022034545A1 (en) Etelcalcetide formulations for parenteral use
JPH10298102A (ja) カルシトニン注射液
WO2006096079A2 (en) Pharmaceutical composition comprising a biosynthetic analog of human insulin, and its use in the treatment of diabetes mellitus.
UA50811C2 (uk) Ліофілізована композиція морфогенетичного фактора кістки, спосіб одержання ліофілізованої композиції морфогенетичного фактора кістки

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees